⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6049109 | 0.92 | MEN1 (0.92) | — | |
| Morpholine SCHEMBL922866 | 0.92 | — | — | |
| Morpholine SCHEMBL18577399 | 0.92 | — | — | |
| Morpholine SCHEMBL986 | 0.92 | — | — | |
| SCHEMBL244992 | 0.92 | MEN1 (0.92) | — | |
| Morpholine SCHEMBL7996463 | 0.92 | MEN1 (0.92) | — | |
| Morpholine SCHEMBL3233209 | 0.92 | MEN1 (0.92) | — | |
| Morpholine SCHEMBL18434 | 0.92 | — | — | |
| SCHEMBL22491036 | 0.92 | MEN1 (0.92) | — | |
| Morpholine SCHEMBL28529603 | 0.92 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023194985-A1 | N-SOYA N-ETHYL MORPHOLINIUM ETHOSULFATE-BASED COMPOSITIONS AND WET WIPES COMPRISING SAME | FISCHER PHARMACEUTICALS LTD. (IL) | 2023-10-12 | — | — | WO | claimed |
| EP-0588906-B2 | PROCESSIBLE FORMS OF ELECTRICALLY CONDUCTIVE POLYANILINE AND CONDUCTIVE PRODUCTS FORMED THEREFROM | DUPONT DISPLAYS INC (US) | 2003-06-18 | — | — | EP | claimed |
| EP-0588906-B1 | PROCESSIBLE FORMS OF ELECTRICALLY CONDUCTIVE POLYANILINE AND CONDUCTIVE PRODUCTS FORMED THEREFROM | UNIAX CORP (US) | 2000-08-02 | — | — | EP | claimed |
| EP-4119560-B1 | APOPTOSIS-INDUCING AGENTS | FOCHON PHARMACEUTICALS LTD (CN) | 2024-06-05 | — | — | EP | disclosed |
| WO-2023194985-A1 | N-SOYA N-ETHYL MORPHOLINIUM ETHOSULFATE-BASED COMPOSITIONS AND WET WIPES COMPRISING SAME | FISCHER PHARMACEUTICALS LTD. (IL) | 2023-10-12 | — | — | WO | disclosed |
| EP-3823628-A1 | <SMALLCAPS/>? ? ?S? ? ? ? ?CERTAIN (2)- <NS1:I>N</NS1:I>?-[(1 <NS2:I>S</NS2:I>?)-1-CYANO-2-PHENYLETHYL]-1,4- OXAZEPANE-2-CARBOXAMIDES FOR TREATING INFLAMMATORY BOWEL DISEASE | Insmed Incorporated (US) | 2021-05-26 | — | — | EP | disclosed |
| EP-3823627-A1 | CERTAIN (2S)-N-[(1S)-1-CYANO-2-PHENYLETHYL]-1,4-OXAZEPANE-2-CARBOXAMIDES FOR TREATING LUPUS NEPHRITIS | Insmed Incorporated (US) | 2021-05-26 | — | — | EP | disclosed |
| EP-3749326-A1 | CERTAIN (2S)-N-[(1S)-1-CYANO-2-PHENYLETHYL]-1,4-OXAZEPANE-2-CARBOXAMIDES FOR TREATING ANCA ASSOCIATED VASCULITIDES | Insmed Incorporated (US) | 2020-12-16 | — | — | EP | disclosed |
| WO-2020018547-A1 | CERTAIN (2S)-N-[(1S)-1-CYANO-2-PHENYLETHYL]-1,4-OXAZEPANE-2-CARBOXAMIDES FOR TREATING LUPUS NEPHRITIS | INSMED INCORPORATED (US) | 2020-01-23 | — | — | WO | disclosed |
| WO-2020018551-A1 | CERTAIN (2S)- N-[(1S)-1-CYANO-2-PHENYLETHYL]-1,4- OXAZEPANE-2-CARBOXAMIDES FOR TREATING INFLAMMATORY BOWEL DISEASE | INSMED INCORPORATED (US) | 2020-01-23 | — | — | WO | disclosed |
| WO-2019157050-A1 | CERTAIN (2S)-N-[(1S)-1-CYANO-2-PHENYLETHYL]-1,4-OXAZEPANE-2-CARBOXAMIDES FOR TREATING ANCA ASSOCIATED VASCULITIDES | INSMED INCORPORATED (US) | 2019-08-15 | — | — | WO | disclosed |
| EP-1368323-B1 | PYRIMIDINE MATRIX METALLOPROTEINASE INHIBITORS | WARNER LAMBERT CO (US) | 2010-06-30 | — | — | EP | disclosed |
| US-7335154-B2 | Radiotherapy | ALGETA AS (NO) | 2008-02-26 | — | — | US | disclosed |
| US-20060135842-A1 | Radiotherapy | ALGETA AS (NO) | 2006-06-22 | — | — | US | disclosed |
| EP-1531904-A1 | COMBINATION OF AN ALLOSTERIC INHIBITOR OF MATRIX METALLOPROTEINASE-13 WITH A SELECTIVE INHIBITOR OF CYCLOOXYGENASE-2 THAT IS NOT CELECOXIB OR VALDECOXIB | Warner-Lambert Company LLC (US) | 2005-05-25 | — | — | EP | disclosed |
| WO-2004007024-A1 | COMBINATION OF AN ALLOSTERIC INHIBITOR OF MATRIX METALLOPROTEINASE-13 WITH A SELECTIVE INHIBITOR OF CYCLOOXYGENASE-2 THAT IS NOT CELECOXIB OR VALDECOXIB | WARNER-LAMBERT COMPANY LLC (US) | 2004-01-22 | — | — | WO | disclosed |
| CN-1349743-A | Green additive for promoting animal's growth and its production process | SANFANGYUAN INFORMATION TECHN (CN) | 2002-05-22 | — | — | CN | disclosed |
| CN-1333370-A | Crops capable of resisting virus diseases of poultry and production method thereof | SHENZHEN SANFANGYUAN INFORMATI (CN) | 2002-01-30 | — | — | CN | disclosed |
| CN-1319670-A | Foot-and-mouth disease virus gene engineered vaccine of domestic animal and preparation process thereof | SHENZHEN SANFANGYUAN INFORMATI (CN) | 2001-10-31 | — | — | CN | disclosed |
| US-4310589-A | ANTIALLERGENS | FARMITALIA CARLO ERBA S.P.A. (IT) | 1982-01-12 | — | — | US | disclosed |